Literature DB >> 23116454

Expression of CD25 independently predicts early treatment failure of acute myeloid leukaemia (AML).

Jan Cerny, Hongbo Yu, Muthalagu Ramanathan, Glen D Raffel, William V Walsh, Natasha Fortier, Lindsey Shanahan, Elizabeth O'Rourke, Jayde Bednarik, Bruce Barton, Aimee Kroll-Desrosiers, Suyang Hao, Bruce Woda, Lloyd Hutchinson, Andrew M Evens, Alan G Rosmarin, Rajneesh Nath.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23116454     DOI： 10.1111/bjh.12109

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  17 in total

1.  CD25 expression and outcomes in older patients with acute myelogenous leukemia treated with plerixafor and decitabine.

Authors:  John N Allan; Gail J Roboz; Gulce Askin; Ellen Ritchie; Joseph Scandura; Paul Christos; Duane C Hassane; Monica L Guzman
Journal:  Leuk Lymphoma       Date:  2017-07-18

2.  Novel signaling axis in CML-initiating cells.

Authors:  Cheng Cheng Zhang
Journal:  Blood       Date:  2014-04-17       Impact factor: 22.113

3.  Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein.

Authors:  Veronika Bachanova; Sarah Cooley; Todd E Defor; Michael R Verneris; Bin Zhang; David H McKenna; Julie Curtsinger; Angela Panoskaltsis-Mortari; Dixie Lewis; Keli Hippen; Philip McGlave; Daniel J Weisdorf; Bruce R Blazar; Jeffrey S Miller
Journal:  Blood       Date:  2014-04-09       Impact factor: 22.113

Review 4.  Concise review: Leukemia stem cells in personalized medicine.

Authors:  Monica L Guzman; John N Allan
Journal:  Stem Cells       Date:  2014-04       Impact factor: 6.277

Review 5.  Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer.

Authors:  Antonieta Chavez-Gonzalez; Babak Bakhshinejad; Katayoon Pakravan; Monica L Guzman; Sadegh Babashah
Journal:  Cell Oncol (Dordr)       Date:  2016-09-27       Impact factor: 6.730

6.  [Analysis of immunophenotypes and expressions of non-myeloid antigens in acute myeloid leukemia].

Authors:  Weiwei Wang; Yuanhong Xu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-11-30

7.  Prognostic Relevance of Cytokine Receptor Expression in Acute Myeloid Leukemia: Interleukin-2 Receptor α-Chain (CD25) Expression Predicts a Poor Prognosis.

Authors:  Kazunori Nakase; Kenkichi Kita; Taiichi Kyo; Takanori Ueda; Isao Tanaka; Naoyuki Katayama
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

Review 8.  Targeting Immunophenotypic Markers on Leukemic Stem Cells: How Lessons from Current Approaches and Advances in the Leukemia Stem Cell (LSC) Model Can Inform Better Strategies for Treating Acute Myeloid Leukemia (AML).

Authors:  Kelly Mitchell; Ulrich Steidl
Journal:  Cold Spring Harb Perspect Med       Date:  2020-01-02       Impact factor: 6.915

9.  Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine.

Authors:  P Miltiades; E Lamprianidou; T P Vassilakopoulos; S G Papageorgiou; A G Galanopoulos; S Vakalopoulou; V Garypidou; M Papaioannou; E Hadjiharissi; V Pappa; H A Papadaki; E Spanoudakis; K Tsatalas; I Kotsianidis
Journal:  Blood Cancer J       Date:  2014-02-28       Impact factor: 11.037

10.  Adaptive immunity-related gene expression profile is correlated with clinical phenotype in patients with acute myeloid leukemia.

Authors:  Peng Chen; Yi Liu; Rui Zhang; Haitao Wang; Juan Zhang; Meng Guo; Zhenlan Du
Journal:  Ann Transl Med       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.